Lakefront Biotherapeutics NV (LKFT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€23.26

Buy

€23.32

arrow-down€-0.10 (-0.43%)

Prices updated at 12 May 2026, 16:01 CEST

Prices minimum 15 mins delay

Prices in EUR

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.

FTSE EuroFirst 300

-1.03%

Amsterdam

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	€23.40 - €22.92
	€32.74 - €22.24
	-
	1,582.85m
	3.16
	-
	29,635
	0.47
	99,635.80
	0.18
	65.90m
	BE0003818359
	7.42
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.